As a component of the Society for Immunotherapy of Cancer's (SITC) regional, live Advances in Cancer Immunotherapy™ (ACI) programs, SITC is pleased to offer free online, introductory, CME-, CPE- and CNE-accredited programs via the society's online learning portal, SITC Cancer Immunotherapy connectED.These online activities provide an overview of basic immunology principles and the mechanisms and clinical applications of immunotherapy.
If you missed the opportunity to attend an Advances in Cancer Immunotherapy™ event, you can still obtain the education and CME, CPE and/or CNE credits through the Advances in Cancer Immunotherapy™ 2017 Video Series online modules.
Exemplar video presentations from the live ACI programs are used as content for the online, CE-certified classes.
Log in to the free ACI webinars to learn about new treatment approvals and emerging scientific data relating to clinical applications of cancer immunotherapy. Hosted by experts in the field, the webinars provide an opportunity to continue your learning from this ACI program and interact with faculty during a dedicated question-and-answer session.2019 Webinars
Advances in Cancer ImmunotherapyTM Webinar Series - Updates from the FieldThursday, May 23, 2019; 3-4 p.m. CST
Robert Canter, MD, MAS, FACS - University of California Davis Health System
Robert L. Ferris, MD, PhD - UPMC Hillman Cancer Center
Click here to register!2018 Webinar Recordings
Participate in these short, interactive online classes to deepen your understanding of what you learned at today’s ACI program in cancer immunotherapy. Learn about specific disease states and practical barriers to implementation while engaging with case study examples. Each class will take approximately 30 minutes to complete and is also eligible for CME, CNE or CPE credits.More information coming soon!
Ask questions as leading experts discuss the most recent immunotherapy treatment standards for specific disease states – stemming from SITC’s Cancer Immunotherapy Guidelines.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com